Aspartate aminotransferase/alanine aminotransferase ratio is associated with hyperuricemia in type 2 diabetic populations: a cross-sectional study
Abstract Background Aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio has been shown to be associated with type 2 diabetes and its complications. The aim of this paper is to investigate the relationship between AST/ALT ratio and hyperuricemia in a type 2 diabetes population. Methods There were 1997 subjects, 597 of whom had hyperuricemia. Multivariate binary logistic regression analysis was applied to explore the correlation between AST/ALT ratio and hyperuricemia. Stratified by gender and body mass index (BMI), the predictive value of different subgroups was compared. Results The risk of hyperuricemia in patients with type 2 diabetes mellitus (T2DM) is negatively correlated with AST/ALT ratio. In unadjusted models, each standard deviation (SD) increase in AST/ALT ratio was associated with a 64% reduction in the risk of hyperuricemia (95% CI: 0.27,0.48; P < 0.001). After adjusting for sex, gender, body mass index (BMI), fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c), the adjusted odds ratio (OR) and 95% confidence interval (CI) of model 4 was 0.54 (0.35,0.82). Conclusion AST/ALT ratio is associated with the risk of hyperuricemia in patients with T2DM, especially in overweight and young adults.
Authors
- Qianhui Cui
- Jingqiu Cui
- Meng Wang
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11193816/v1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- preprint
Funders
- National Natural Science Foundation of China
- Tianjin Medical University